Skip to main content
Figure 2 | BMC Dermatology

Figure 2

From: Employment is maintained and sick days decreased in psoriasis/psoriatic arthritis patients with etanercept treatment

Figure 2

Percent of patients employed and who changed job responsibilities due to arthritis symptoms or psoriasis symptoms. A: Percent of patients employed. *p < 0.003 for within-group comparisons to baseline (McNemar’s test); p > 0.05 for between-group comparisons (Cochran-Mantel-Haenszel test). B: Percent of patients employed who changed job responsibilities in the previous month due to arthritis symptoms. *p < 0.004 for within-group comparisons to baseline (McNemar’s test); p > 0.05 for between-group comparisons (Cochran-Mantel-Haenszel test). C: Percent of patients employed who changed job responsibilities in the previous month due to psoriasis symptoms. *p < 0.009 for within-group comparisons to baseline (McNemar’s test); p > 0.05 for between-group comparisons (Cochran-Mantel-Haenszel test). BIW: twice weekly; ETN: etanercept; QW: once weekly.

Back to article page